Scientific Name: Meloxicam
Brand Name: Anjeso, Mobic, Qmiiz, Vivlodex
Company Owner: Boehringer ingelheim pharmaceuticals inc, Actavis totowa llc, Apotex inc etobicoke site, Aurobindo pharma ltd, Beijing double crane pharmaceutical co ltd, Beijing yabao biopharmaceutical co ltd, Breckenridge pharmaceutical inc, Caraco pharmaceutical laboratories ltd, Carlsbad technology inc, Corepharma llc, Dr reddys laboratories inc, Genpharm inc, Glenmark generics ltd, Lupin pharmaceuticals inc, Mutual pharmaceutical co inc, Mylan pharmaceuticals inc, Roxane laboratories inc, Strides arcolab ltd, Taro pharmaceutical industries ltd, Teva pharmaceuticals usa, Unichem laboratories ltd, Watson laboratories inc, Zydus pharmaceuticals usa inc
Mechanism Of Action Meloxicam inhibits prostaglandin synthetase (cylooxygenase 1 and 2) enzymes leading to a decreased synthesis of prostaglandins, which normally mediate painful inflammatory symptoms.
Description of the Drug: Meloxicam is an NSAID used to treat osteoarthritis in adults, rheumatoid arthritis in adults, and juvenile rheumatoid arthritis in pediatrics.
Protein Data Bank:
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB00814